指南与共识老年综合评估多重用药认知障碍与谵妄

生成式人工智能在老年人照护中的应用:美国老年医学会立场声明

Generative AI in the Care of Older Adults: A Position Statement From the American Geriatrics Society.
指南 / 共识 · J Am Geriatr Soc · 2026-07-21

美国老年医学会(AGS)召集跨学科工作组,经文献回顾和多委员会审核,于2026年3月发布立场声明,将个体化照护、公平、共享决策和促进独立等老年医学原则转化为对临床医生、卫生系统、开发者、政策制定者、老年人及照护伙伴的可操作建议,强调GenAI应增强而非替代临床判断和关系性照护。

要点

  • GenAI应增强而非替代临床判断和关系性照护。
  • 老年医学核心任务在训练数据中可能代表性不足且实践风险高。
  • 负责任使用需透明、临床医生在环监督和年龄相关结局验证。

核心结论

  • GenAI应增强而非替代临床判断和关系性照护,负责任使用需透明、临床医生在环监督、在老年人群中用年龄相关结局验证及治理保障以保护尊严、安全和公平。

研究设计与样本

  • 美国老年医学会(AGS)召集跨学科工作和写作组,回顾相关文献和报告,纳入多个AGS委员会意见,并于2026年3月通过AGS委员会流程完成审查和批准。

主要发现

  • GenAI正被整合到医疗文档、决策支持、患者教育、行政工作流程及可发起临床和运营行动的代理系统中。
  • GenAI可能减轻临床医生负担并支持个体化照护,但也引入错误信息、算法偏见、隐私伤害、遗漏错误和自动化过度依赖等风险。
  • 由于老年医学核心照护任务在训练数据中可能代表性不足且实践高风险,这些风险对老年人可能被放大。

关键数值与推荐

  • 建议涉及伦理使用、临床整合与监督、透明与文档、隐私保护、AI全生命周期治理(包括部署前、中、后监测与问责)及优先老年医学用例。

临床怎么用

  • 临床医生应将GenAI作为辅助工具而非替代临床判断,并在老年照护中保持临床医生在环监督。
  • 卫生系统和开发者应在老年人群中用年龄相关结局验证GenAI工具,并确保透明和隐私保护。
  • 政策制定者应建立治理保障措施,覆盖AI全生命周期监测与问责,以保护老年人尊严、安全和公平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Generative artificial intelligence (GenAI), particularly large language models (LLMs), is being integrated into healthcare documentation, decision support, patient education, administrative workflows, and emerging agentic systems capable of initiating clinical and operational actions. While GenAI may reduce clinician burden and support person-centered care, it also introduces risks such as misinformation, algorithmic bias, privacy harms, errors of omission, and automation over-reliance. These risks may be amplified for older adults because core geriatrics care tasks, such as goals-of-care discussions, capacity-sensitive consent, polypharmacy and deprescribing, and functional and cognitive assessment in the setting of multimorbidity, may be underrepresented in training data and are high-stakes in practice. METHODS: The American Geriatrics Society (AGS) convened an interdisciplinary working and writing group, reviewed relevant literature and reports, incorporated input from multiple AGS committees, and completed review and approval through AGS committee processes in March 2026. RESULTS: This AGS position statement translates core geriatrics principles, person-centered care, equity, shared decision-making, and promoting independence into actionable recommendations for clinicians, health systems, developers, policymakers, older adults, and care partners. Recommendations address ethical use, clinical integration and oversight, transparency and documentation, privacy protections, governance across the AI lifecycle, including pre, during, and post-deployment monitoring and accountability, and priority geriatrics use cases. CONCLUSION: GenAI should augment, not replace, clinical judgment and relational care. Responsible use in geriatrics requires transparency, clinician-in-the-loop oversight, validation in older adult populations using age-relevant outcomes, and governance safeguards to protect dignity, safety, and equity.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Bharija A, Khan A, Pavon JM, et al. Generative AI in the Care of Older Adults: A Position Statement From the American Geriatrics Society. J Am Geriatr Soc. 2026. PMID: 42478489. doi:10.1111/jgs.70566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。